| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $11.18M | -2,034 | |
| VP | 109.2K | $5.42M | - | |
| VP | 69.4K | $3.44M | -9,000 | |
| Dir | 43.3K | $2.15M | -44,472 | |
| CFO | 36.7K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $48.58 | $437,220.00 | -11.5% | - | - | |
| Aug 3, 2026 | Snyderman Nancy Lynn Md | Director | Sale+OE | 44,472 | $50.35 | $2,239,076.26 | -74.3% | - | - | |
| Aug 3, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $48.58 | $98,811.72 | -0.9% | - | - | |
| Jul 6, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $54.03 | $109,897.02 | -0.9% | - | - | |
| Jun 12, 2026 | Wright Christopher I | Director | Sell | 2,000 | $45.10 | $90,200.00 | -7.2% | - | - | |
| Jun 1, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $41.67 | $375,043.50 | -10.4% | - | - | |
| May 29, 2026 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 16,217 | $42.36 | $687,007.26 | -67.8% | - | - | |
| May 1, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $33.40 | $300,559.50 | -10.0% | +49.9% | - | |
| Feb 2, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $33.93 | $305,384.50 | -7.0% | -4.5% | - | |
| Feb 2, 2026 | Cooke Shane62 | Director | Sale+OE | 61,200 | $34.57 | $2,115,672.52 | -20.3% | -4.5% | - |